Northwest Bancshares’s Gilead Sciences GILD Stock Holding History

Northwest Bancshares’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Buy	19,719 +17,799	+927%	+$2.35M	0.45%	58
2026 Q1	$268K	Hold	1,920	–	–	0.05%	144
2025 Q4	$236K	Buy	+1,920	New	+$233K	0.05%	155
2025 Q3	–	Sell	-1,822	Closed	-$202K	–	186
2025 Q2	$202K	Hold	1,822	–	–	0.04%	183
2025 Q1	$204K	Buy	+1,822	New	+$188K	0.04%	179
2020 Q2	–	Sell	-52,425	Closed	-$3.92M	–	225
2020 Q1	$3.92M	Buy	52,425 +2,776	+6%	+$192K	1.95%	11
2019 Q4	$3.23M	Buy	49,649 +5,001	+11%	+$326K	1.25%	33
2019 Q3	$2.83M	Buy	44,648 +1,590	+4%	+$104K	1.17%	38
2019 Q2	$2.91M	Buy	43,058 +1,800	+4%	+$118K	1.23%	26
2019 Q1	$2.68M	Buy	41,258 +4,021	+11%	+$267K	1.16%	35
2018 Q4	$2.33M	Buy	37,237 +8,421	+29%	+$589K	1.12%	26
2018 Q3	$2.22M	Buy	28,816 +2,344	+9%	+$177K	0.98%	25
2018 Q2	$1.88M	Buy	26,472 +1,118	+4%	+$78.9K	0.79%	27
2018 Q1	$1.91M	Buy	25,354 +1,698	+7%	+$135K	0.78%	27
2017 Q4	$1.69M	Buy	+23,656	New	+$1.8M	0.69%	33

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwest Bancshares's GILD Position: Q2 2026 in Review

Northwest Bancshares increased its Gilead Sciences (GILD) stake by 927% in Q2 2026, buying an estimated $2.35M and bringing the position to 19,719 shares worth $2.49M. The position accounts for 0.45% of the portfolio, ranked #58.

Northwest Bancshares first reported a position in GILD in Q4 2017 and has held it in 15 quarters since. The position peaked at $3.92M in Q1 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Northwest Bancshares held 19,719 shares of Gilead Sciences worth $2.49M as of Q2 2026.
Northwest Bancshares bought 17,799 Gilead Sciences shares in Q2 2026, an estimated $2.35M.
Gilead Sciences made up 0.45% of Northwest Bancshares's portfolio in Q2 2026, its #58 holding.
Northwest Bancshares first reported a position in Gilead Sciences in Q4 2017 and has held it in 15 quarters since.
Northwest Bancshares's Gilead Sciences position peaked at $3.92M in Q1 2020.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Northwest Bancshares's 13F filing for Q2 2026, filed 14 Aug 2026.